Mechanisms of Mitochondrial Transport in the Nervous System
Mechanisms of Mitochondrial Transport in the Nervous System
Neurons have highly polarized structures, with axons and dendrites extending far from the soma. Synaptic activity, action potential conduction, Ca²⁺ buffering, and local protein homeostasis all depend on continuous mitochondrial energy supply. Directed mitochondrial transport, local docking, fusion-fission dynamics, and quality control within neurons jointly determine the energy supply and functional stability of distal neural structures.
Keywords: nervous system; mitochondrial transport; axonal transport; Miro1; Kinesin; Dynein; Ca²⁺ homeostasis; mitochondrial dynamics; neurodegenerative diseases
1 Research Entry Points for Neuronal Mitochondrial Transport
1.1 Dependence of Neurons on Mitochondrial Transport
Different neuronal compartments have distinct energy demands and signaling burdens. The soma is responsible for protein synthesis, organelle renewal, and metabolic integration. Axons rely on ATP to maintain membrane potential, long-distance transport, and local repair. Presynaptic terminals require ATP to support synaptic vesicle cycling, neurotransmitter release, and ion pump activity. Dendrites and dendritic spines depend on mitochondria for Ca²⁺ buffering, synaptic plasticity, and local structural remodeling.
Mitochondria must be transported along the microtubule system to distal axons, dendrites, and synaptic regions. At the same time, some mitochondria dock near synapses, axonal branch points, nodes of Ranvier, or injury sites to maintain local ATP supply and Ca²⁺ homeostasis.
Neuronal Region | Main Demand | Key Mitochondrial Function |
Soma | Protein synthesis, organelle renewal, metabolic integration | ATP generation, mitochondrial biogenesis, quality control |
Axon | Long-distance transport, membrane potential maintenance, local repair | Axonal energy supply, injury response |
Presynaptic terminal | Vesicle cycling, neurotransmitter release, ion pump activity | ATP supply, Ca²⁺ buffering, regulation of synaptic release |
Dendrites and dendritic spines | Synaptic plasticity, receptor trafficking, local translation | Ca²⁺ homeostasis, energy supply, structural plasticity |
Node of Ranvier | Saltatory action potential conduction, Na⁺/K⁺ pump activity | Local ATP supply and ion homeostasis maintenance |
1.2 Core Meaning of Mitochondrial Transport
Neuronal mitochondrial transport is not only an organelle displacement process, but also includes three levels: long-distance transport, local docking, and dynamic renewal. Long-distance transport delivers mitochondria to distal neural structures. Local docking ensures stable mitochondrial positioning in regions with high energy demand or high Ca²⁺ burden. Dynamic renewal maintains mitochondrial functional status through fusion, fission, and quality control.
Abnormal mitochondrial transport can lead to insufficient local ATP supply, disrupted Ca²⁺ homeostasis, ROS accumulation, impaired synaptic function, and axonal degeneration. Therefore, related studies should simultaneously analyze mitochondrial distribution, motility status, functional status, and the ability to clear damaged mitochondria.
2 Microtubule-Dependent Mitochondrial Transport System
2.1 Kinesin-Mediated Anterograde Transport
Anterograde mitochondrial transport mainly depends on Kinesin motor proteins, especially members of the KIF5 family. Anterograde transport delivers mitochondria from the soma or proximal axon to distal axons, presynaptic terminals, and dendritic regions to meet local energy metabolism and synaptic activity demands.
Kinesin usually participates in mitochondrial transport through mitochondrial outer membrane receptors and adaptor proteins. Miro1/2 are located on the mitochondrial outer membrane and can integrate mitochondrial status and Ca²⁺ signals. TRAK1/2, as Milton homolog adaptor proteins, connect Miro with the Kinesin or Dynein systems. The Miro-TRAK-Kinesin axis is an important regulatory module for anterograde mitochondrial transport.
2.2 Dynein-Dynactin-Mediated Retrograde Transport
Retrograde mitochondrial transport mainly depends on the Dynein motor protein and its regulatory complex Dynactin. Retrograde transport can move aged, damaged, or membrane potential-decreased mitochondria from distal axons back toward the soma. It can also redistribute mitochondria among different axonal segments.
Retrograde transport is important for neuronal quality control. Distal synapses and long axonal regions are prone to local oxidative stress, Ca²⁺ overload, or membrane potential decline. If retrograde transport is impaired, damaged mitochondria may accumulate in distal axons, causing ATP insufficiency, increased ROS, synaptic dysfunction, and axonal degeneration.
2.3 Hub Role of the Miro-TRAK Complex
Miro proteins are located on the mitochondrial outer membrane and can regulate mitochondrial status, Ca²⁺ signaling, and motor binding. TRAK1/2 connect Miro with the Kinesin or Dynein transport systems and participate in regulating both anterograde and retrograde mitochondrial transport. In different neuronal compartments, TRAK1 and TRAK2 may show different localization preferences and regulatory roles in transport direction.

Figure 1. Schematic illustration of anterograde and retrograde mitochondrial transport and local anchoring in neuronal axons
Component Module | Representative Molecules | Main Function |
Microtubule tracks | α/β-Tubulin, MAPs | Provide long-distance transport tracks within axons and dendrites |
Anterograde motors | KIF5/Kinesin family | Transport mitochondria to distal axons and synaptic regions |
Retrograde motors | Dynein-Dynactin complex | Transport mitochondria toward the soma |
Mitochondrial outer membrane receptors | Miro1/RHOT1, Miro2/RHOT2 | Sense mitochondrial status and Ca²⁺ signals |
Adaptor proteins | TRAK1, TRAK2 | Connect Miro with motor proteins and regulate transport efficiency |
Docking factors | Syntaphilin/SNPH and others | Promote local anchoring of axonal mitochondria |
3 Mitochondrial Docking and Local Energy Supply
3.1 Transition Between Motile and Stationary States
Mitochondria in neurons are not continuously moving. A considerable proportion of axonal mitochondria are stationary and dock at presynaptic regions, axonal branch points, or high-energy-demand regions. Motile mitochondria are responsible for long-distance supply and renewal, while stationary mitochondria provide local ATP supply and Ca²⁺ buffering.
The transition of mitochondria from a motile state to a docked state is usually associated with increased local neuronal activity, elevated Ca²⁺, increased energy demand, or axonal injury. This process helps stabilize mitochondria in functionally active regions.
3.2 Syntaphilin-Mediated Axonal Mitochondrial Anchoring
Syntaphilin (SNPH) is an important regulatory protein for axonal mitochondrial docking. It can anchor mitochondria near microtubules and restrict their movement. SNPH-mediated docking helps maintain mitochondrial supply in synaptic regions, but excessive docking may reduce the renewal efficiency of damaged mitochondria, making abnormal mitochondria difficult to remove in time.
3.3 Effect of Synaptic Activity on Mitochondrial Localization
When synaptic activity increases, local Ca²⁺ levels rise and ATP consumption increases. Mitochondria staying near synapses can rapidly buffer Ca²⁺ and provide ATP to support synaptic vesicle recycling, membrane potential recovery, and neurotransmitter release. If mitochondria cannot effectively reach or remain in synaptic regions, synaptic transmission efficiency and synaptic plasticity may both be impaired.
4 Regulation of Mitochondrial Transport by Ca²⁺ Signaling
4.1 Ca²⁺ Participates in Activity-Dependent Mitochondrial Localization
Ca²⁺ is an important signaling molecule in neuronal excitatory activity and a key variable in the regulation of mitochondrial transport. Increased cytosolic Ca²⁺ does not simply promote mitochondrial movement. During glutamate receptor-dependent synaptic activity, Miro1 can act as a Ca²⁺ sensor and regulate mitochondrial localization near synapses, making mitochondria more likely to remain in highly active regions.
Therefore, the effect of Ca²⁺ on mitochondrial transport should be understood as activity-dependent localization regulation rather than unidirectional enhancement or inhibition of transport.
4.2 Miro1-Mediated Ca²⁺ Sensing
Miro1 contains domains related to Ca²⁺ binding and can sense local Ca²⁺ changes. When synaptic activity causes cytosolic Ca²⁺ elevation, the interactions within Miro1-related transport complexes change, shifting mitochondria from a motile state to a locally docked state. This mechanism can enrich mitochondria in regions with high Ca²⁺ burden and high energy demand, supporting synaptic transmission and local signal stability.
4.3 Mitochondrial Ca²⁺ Uptake and Neuronal Homeostasis
Mitochondria are important hubs in the cellular Ca²⁺ signaling regulatory network. Mitochondria take up Ca²⁺ through related transport systems and participate in regulating cytosolic Ca²⁺ peaks, metabolic enzyme activity, ATP production, and cell death signaling. Moderate Ca²⁺ entry into mitochondria can enhance metabolic activity, whereas excessive Ca²⁺ uptake can induce membrane potential decline, ROS elevation, and cellular injury.
Ca²⁺ Change | Effect on Mitochondria | Physiological or Pathological Significance |
Transient local Ca²⁺ increase | Promotes mitochondrial docking near active synapses | Supports synaptic release and Ca²⁺ buffering |
Sustained Ca²⁺ increase | Inhibits mitochondrial movement and increases metabolic pressure | May aggravate local mitochondrial burden |
Moderate mitochondrial Ca²⁺ uptake | Enhances metabolic enzyme activity and ATP production | Matches neuronal activity demand |
Mitochondrial Ca²⁺ overload | Induces membrane potential decline and ROS accumulation | Increases the risk of neuronal injury |
5 Mitochondrial Fusion, Fission, and Transport Capacity
5.1 Fusion Maintains Mitochondrial Functional Integrity
Mitochondrial fusion promotes exchange of mitochondrial contents, restoration of membrane potential, and dilution of damaged components. Outer membrane fusion is mainly mediated by Mitofusin 1/2 (Mfn1/2), while inner membrane fusion is mainly mediated by OPA1. Fusion helps maintain mitochondrial network functional stability and is especially protective under metabolic stress and mild injury conditions.
In addition to participating in mitochondrial fusion, Mfn2 is also associated with mitochondrial transport, endoplasmic reticulum-mitochondria contacts, and axonal mitochondrial distribution. Abnormal Mfn2 can affect mitochondrial supply in peripheral nerve axons and represents an important mechanistic basis for some hereditary neuropathies.
5.2 Fission Promotes Mitochondrial Renewal and Local Allocation
Mitochondrial fission is mainly mediated by Drp1. Drp1 is recruited from the cytosol to the mitochondrial outer membrane and forms constriction structures with the participation of receptors or regulatory proteins such as Mff, MiD49, MiD51, and Fis1, thereby promoting mitochondrial fission. Moderate fission can generate small mitochondrial units suitable for axonal transport and facilitate separation of damaged regions for subsequent clearance.
Excessive Drp1 activation leads to mitochondrial fragmentation, membrane potential decline, and enhanced neuronal stress. In a neuronal injury model induced by the complex II inhibitor 3-NP, mitochondrial fragmentation and neuronal death are related to NMDA receptor- and ROS-dependent mechanisms. In Alzheimer’s disease-related research, abnormal Drp1 is also closely associated with mitochondrial dynamics imbalance and pathological progression.
5.3 Dynamic Balance Determines Transport Efficiency
Excessive mitochondrial fusion may produce overly large mitochondria that are unfavorable for long-distance axonal transport, whereas excessive fission may generate fragmented mitochondria with insufficient function. Neurons need to maintain balance among fusion, fission, transport, and anchoring to preserve mitochondrial quality at distal synapses.
Dynamic Process | Key Molecules | Functional Significance | Consequences of Abnormality |
Outer membrane fusion | Mfn1, Mfn2 | Promotes mitochondrial connection and content exchange | Insufficient fusion causes functional dispersion and axonal energy supply deficits |
Inner membrane fusion | OPA1 | Maintains cristae structure and membrane potential stability | OPA1 abnormality can affect respiratory chain efficiency |
Fission | Drp1, Mff, MiD49/51, Fis1 | Promotes mitochondrial allocation and quality control | Excessive fission causes fragmentation and ROS elevation |
Docking | SNPH and others | Maintains local energy supply | Excessive docking affects renewal of damaged mitochondria |
Long-distance transport | Miro, TRAK, Kinesin, Dynein | Maintains mitochondrial distribution in axons and synapses | Transport defects lead to impaired distal axonal and synaptic function |
6 Regulation of Mitochondrial Transport by Neurotrophic Factors
6.1 NGF Signaling Regulates Axonal Mitochondrial Motility and Docking
Neurotrophic factors can regulate neuronal survival, axonal growth, synaptic function, and mitochondrial distribution through receptor tyrosine kinase pathways. NGF signaling can regulate the motility and docking of axonal mitochondria, allowing mitochondria to be more effectively positioned in axonal and growth-related regions.
This process is related to downstream pathways such as PI3K-AKT and MAPK-ERK, reflecting the regulatory role of neurotrophic factors in mitochondrial transport and local metabolic adaptation in neurons.
6.2 BDNF and Synaptic Mitochondrial Function
BDNF-TrkB signaling can promote synaptic activity-related metabolic adaptation and affect mitochondrial respiration, membrane potential, and local localization. The effect of BDNF on mitochondrial dynamics is context-dependent and should not be simply described as unidirectionally promoting fusion or inhibiting fission. Under different stimulation intensities, neuronal types, and disease models, BDNF may influence mitochondrial morphology and function by regulating Drp1, Mfn, PGC-1α, or other metabolic pathways.
6.3 Neurotrophic Factor Deficiency and Abnormal Mitochondrial Distribution
When neurotrophic factors are insufficient, mitochondrial supply to distal axons and synaptic regions may decline, leading to local ATP insufficiency, impaired Ca²⁺ homeostasis, and weakened synaptic function. In neurodegenerative disease and axonal injury models, reduced neurotrophic factor signaling often occurs together with mitochondrial transport defects.
7 Mitochondrial Quality Control and Axonal Transport
7.1 Recognition and Clearance of Damaged Mitochondria
Neurons are long-lived cells with long processes and are highly dependent on mitochondrial quality control. If damaged mitochondria are not cleared in time, they can cause ATP decline, ROS elevation, reduced Ca²⁺ buffering capacity, and enhanced cell death signaling.
The PINK1-Parkin pathway is one of the important mechanisms of mitophagy. When mitochondrial membrane potential decreases, PINK1 accumulates on the mitochondrial outer membrane and recruits Parkin, promoting ubiquitination of outer membrane proteins and initiating damaged mitochondria clearance programs.
7.2 Relationship Between Transport and Mitophagy
Clearance of damaged mitochondria can occur locally in axons or be associated with retrograde transport. For damaged mitochondria in distal axons, retrograde transport capacity determines whether they can be transported to the soma or proximal degradation regions. If Dynein-mediated retrograde transport is impaired, damaged mitochondria may accumulate in distal axons and become a persistent source of injury.
7.3 Miro Degradation and Transport Arrest
After activation of PINK1-Parkin, Miro degradation can be promoted, causing damaged mitochondria to detach from transport motors and restricting further movement of damaged mitochondria. This process helps isolate damaged mitochondria and creates conditions for subsequent autophagic clearance. Abnormal Miro regulation affects the coordination between mitochondrial quality control and transport.
8 Abnormal Mitochondrial Transport Under Pathological Conditions
8.1 Alzheimer’s Disease
In Alzheimer’s disease, abnormal Tau phosphorylation, Aβ toxicity, decreased microtubule stability, and synaptic injury can all affect mitochondrial transport. Tau abnormality can interfere with microtubule tracks and motor protein movement, making it difficult for mitochondria to effectively reach distal axons and synaptic regions. Insufficient synaptic mitochondria aggravate reduced energy supply, Ca²⁺ imbalance, and impaired synaptic transmission. Drp1 abnormality is also closely related to mitochondrial dynamics disorder in Alzheimer’s disease.
8.2 Parkinson’s Disease
Parkinson’s disease is closely associated with mitochondrial dysfunction and abnormal quality control. PINK1, Parkin, DJ-1, LRRK2, and related molecules can all affect mitochondrial homeostasis. When the PINK1-Parkin pathway is impaired, damaged mitochondria are difficult to clear in time, leading to increased ROS, decreased membrane potential, and increased vulnerability of dopaminergic neurons. Impaired Miro degradation may also affect transport arrest and clearance of damaged mitochondria.
8.3 Amyotrophic Lateral Sclerosis
In amyotrophic lateral sclerosis (ALS), abnormalities involving SOD1, TDP-43, FUS, C9orf72, and related factors can affect mitochondrial morphology, axonal transport, and energy metabolism. Motor neurons have long axons and high energy demand and are especially sensitive to mitochondrial transport defects. Insufficient mitochondrial supply at the neuromuscular junction affects synaptic transmission and axonal stability.
8.4 Huntington’s Disease and Hereditary Peripheral Neuropathy
Mutant Huntingtin can interfere with mitochondrial transport along microtubules and affect BDNF axonal transport and energy metabolism. Hereditary peripheral neuropathies such as CMT2A are closely associated with MFN2 mutations, indicating a direct link among mitochondrial fusion, transport, and axonal maintenance.
Disease Type | Related Abnormality | Effect on Mitochondrial Transport | Main Consequence |
Alzheimer’s disease | Abnormal Tau phosphorylation, Aβ toxicity, Drp1 abnormality | Damaged microtubule tracks and reduced axonal mitochondrial supply | Synaptic dysfunction and energy deficiency |
Parkinson’s disease | Abnormal PINK1/Parkin pathway | Impaired transport arrest and clearance of damaged mitochondria | ROS accumulation and dopaminergic neuronal injury |
ALS | Abnormal SOD1, TDP-43, FUS, etc. | Axonal transport defects and mitochondrial fragmentation | Motor neuron degeneration |
Huntington’s disease | Mutant Huntingtin | Motor protein and microtubule transport are disturbed | Insufficient axonal energy supply |
CMT2A | MFN2 mutation | Abnormal fusion and axonal mitochondrial distribution | Peripheral nerve axonal degeneration |
9 Product Selection Related to Mitochondrial Transport Mechanism Research in the Nervous System
Product Module | Cat. No. | Product Name | Grade & Purity | Application Positioning |
Mitochondrial tracing | MitoTracker Deep Red FM (Mitochondrial red fluorescent probe) | BioReagent, biological stain, suitable for fluorescence analysis, for microscopy, ≥97% | Used for live-cell mitochondrial labeling and observation of mitochondrial distribution in neuronal axons, dendrites, and soma | |
Mitochondrial tracing | MitoTracker Orange CMTMRos (Mitochondrial orange fluorescent probe) | BioReagent, biological stain, suitable for fluorescence analysis, for microscopy, ≥98% | Used for functional mitochondrial tracing and supporting observations related to mitochondrial localization and membrane potential | |
Mitochondrial outer membrane marker | Recombinant TOMM20 Antibody | Recombinant, ExactAb™, validated, 0.3 mg/mL | Used for IF/WB/IHC labeling of the mitochondrial outer membrane and analysis of mitochondrial morphology, quantity, and axonal distribution | |
Mitochondrial outer membrane marker | Recombinant Human TOMM20 Protein | Carrier-free, His tag, ≥95%(SDS-PAGE), see COA | Used for TOMM20-related antibody validation, standards, or mitochondrial outer membrane marker research | |
Mitochondrial outer membrane/content marker | VDAC1/Porin Antibody | Recombinant, ExactAb™, validated, see COA | Used to detect mitochondrial outer membrane protein and mitochondrial content, assisting analysis of mitochondrial function and transport | |
Mitochondrial outer membrane/content marker | Recombinant Human VDAC1 Protein | ≥90%(SDS-PAGE) | Used for VDAC1-related antibody validation or mitochondrial outer membrane protein research | |
Mitochondrial content detection | Human Voltage-dependent Anion-selective Channel 1 (VDAC1) ELISA Kit | BioReagent | Used for detecting VDAC1 levels in human-derived samples and assisting in evaluating mitochondrial content or outer membrane protein changes | |
Mitochondrial content detection | Mouse Voltage-dependent Anion-selective Channel 1 (VDAC1) ELISA Kit | BioReagent | Used for detecting VDAC1 levels in mouse nervous system models | |
Microtubule track marker | Recombinant Alpha Tubulin Antibody | Recombinant, ExactAb™, validated, 0.25 mg/mL | Used to detect microtubule structures and assist in analyzing the integrity of mitochondrial axonal transport tracks | |
Microtubule track marker | Recombinant beta Tubulin Antibody | Recombinant, ExactAb™, validated, 0.2 mg/mL | Used to detect β-Tubulin and analyze the relationship between microtubule tracks and mitochondrial transport defects | |
Neuronal/microtubule marker | Recombinant beta III Tubulin Antibody | Recombinant, ExactAb™, validated, high performance, 0.088 mg/mL | Used for neuronal labeling and axon/dendrite structure observation, assisting localization of mitochondrial distribution regions | |
Microtubule fluorescence tracing | Tubulin-Tracker Green |
| Used for fluorescent labeling of microtubule structures and suitable for combined observation of transport tracks with mitochondrial probes | |
Microtubule fluorescence tracing | Tubulin-Tracker Red |
| Used for microtubule structure imaging and assisting analysis of the effect of microtubule disruption on mitochondrial transport | |
Anterograde transport motor | KIF5A Antibody | Validated, 1.0 mg/mL | Used to detect Kinesin family anterograde transport motors and analyze mechanisms of mitochondrial transport toward distal axons | |
Retrograde transport motor | Recombinant Dynein intermediate chain 1/DNAI1 Antibody | Recombinant, ExactAb™, validated, see COA | Used to detect Dynein-related retrograde transport components and analyze damaged mitochondrial recycling and soma-directed transport | |
Retrograde transport motor | Recombinant Human Dynein Protein | Carrier-free, His tag, ≥90%(SDS-PAGE), see COA | Used for Dynein-related mechanistic research or antibody/binding assay validation | |
Dynein complex | Recombinant Human Dynein light chain 4 Protein | Carrier-free, His tag, ≥90%(SDS-PAGE), expressed in E. coli; see COA | Used for research on Dynein light chain-related transport complexes | |
Retrograde transport complex | DCTN1/p150-glued Mouse mAb | Carrier-free, ExactAb™, validated, 0.5 mg/mL | Used to detect the core component of the Dynactin complex and analyze Dynein-Dynactin-mediated retrograde transport | |
Mitochondrial fusion regulation | MFN2 agonist-1 | ≥99% | Used to regulate MFN2-related mitochondrial fusion and study the effect of fusion status on axonal mitochondrial distribution and function | |
Mitochondrial fusion detection | Human Mitofusin 2 (MFN2) ELISA Kit | BioReagent | Used to detect MFN2 levels; suitable for research on mitochondrial fusion, axonal distribution, and neuropathic mechanisms | |
Mitochondrial fission detection | DRP1 Mouse mAb | See COA | Used to detect Drp1 and analyze mitochondrial fission, fragmentation, and neuronal injury mechanisms | |
Mitochondrial fission inhibition | Mdivi-1 | ≥96% | Used to inhibit Drp1-related mitochondrial fission and analyze the effect of excessive fission on neuronal mitochondrial transport and injury | |
Drp1/GTPase intervention | MB 0223 | ≥98%(HPLC) | Used to interfere with Drp1 GTPase activity and study the relationship between mitochondrial fission and transport defects | |
Microtubule disruption model | Nocodazole | ≥98% | Used for microtubule depolymerization experiments to verify the dependence of mitochondrial transport on microtubule tracks | |
Ca²⁺ intervention | BAPTA-AM | ≥95% | Used for cytosolic Ca²⁺ chelation to verify the regulatory effect of Ca²⁺ elevation on mitochondrial docking and transport | |
Mitochondrial depolarization model | Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) | Moligand™, ≥98% | Used to induce mitochondrial membrane potential decline and establish PINK1/Parkin-related mitochondrial injury or mitophagy models |
10 Common Misinterpretations in Mitochondrial Transport Mechanism Research
10.1 Equating Mitochondrial Quantity Changes with Transport Changes
Changes in mitochondrial quantity or fluorescence intensity cannot directly represent transport capacity. Mitochondrial quantity may be jointly affected by biogenesis, fission, fusion, degradation, and staining efficiency. Transport abnormalities should be judged based on dynamic imaging and motility parameters.
10.2 Simply Interpreting Ca²⁺ Elevation as Promoting Movement
The effect of Ca²⁺ on mitochondrial transport is region- and concentration-dependent. Local Ca²⁺ elevation often promotes mitochondrial docking near active synapses rather than continuously enhancing long-distance movement.
10.3 Detecting Only Drp1 While Ignoring Fusion and Transport
Mitochondrial fragmentation may be related to Drp1 activation, but it may also result from insufficient fusion, membrane potential decline, or abnormal quality control. Mfn1/2, OPA1, membrane potential, and motility parameters should be evaluated together.
10.4 Equating PINK1/Parkin Abnormality with Complete Mitophagy Defects
PINK1-Parkin is an important mitophagy pathway, but it is not the only mechanism. Under different neuronal types and injury conditions, Parkin-independent mitochondrial quality control pathways may still exist.
The core of mitochondrial transport mechanisms in the nervous system lies in regional mitochondrial positioning and quality control after injury. The Miro-TRAK-motor protein complex determines long-distance transport, Ca²⁺ and SNPH regulate local docking, Mfn1/2, OPA1, and Drp1 control morphological renewal, and pathways such as PINK1-Parkin participate in damaged mitochondrial clearance. Together, these processes maintain neuronal energy homeostasis and synaptic function.
References
[1] Macaskill AF, Rinholm JE, Twelvetrees AE, et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron. 2009;61(4):541-555.
[2] Szabadkai G, Duchen MR. Mitochondria: the hub of cellular Ca²⁺ signaling. Physiology (Bethesda). 2008;23:84-94.
[3] Chada SR, Hollenbeck PJ. Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr Biol. 2004;14(14):1272-1276.
[4] Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ. 2009;16(6):899-909.
[5] Kandimalla R, Reddy PH. Multiple Faces of Dynamin-Related Protein 1 and Its Role in Alzheimer's Disease Pathogenesis. Biochim Biophys Acta Mol Basis Dis. 2016;1862(4):814-828.
危险品化学品经营许可证(带存储)